infect
caus
common
europ
diseas
pattern
quit
differ
diseas
genit
tract
common
respiratori
tract
vari
intens
preval
digest
disord
connect
bhvi
gener
observ
calv
mainli
belgium
viru
strain
caus
abort
enceph
present
countri
true
induc
mastiti
dermat
lesion
interdigit
space
seem
rare
event
infect
frequent
complic
bacteri
secondari
infect
evid
bhvi
infect
occur
simultan
bovin
viru
diarrhoea
bvd
andor
pi
viru
biggest
problem
associ
infect
abil
agent
becom
latent
follow
primari
infect
genom
viru
probabl
remain
life
anim
ganglia
region
primari
infect
occur
vaccin
overcom
latent
stage
prophylact
vaccin
possibl
prevent
outbreak
clinic
diseas
imposs
prevent
infect
follow
establish
latenc
erad
programm
austria
denmark
switzerland
remov
seroposit
cattl
bovin
popul
current
sanitari
programm
also
conduct
germani
rtsmnt
le
infect
avec
le
viru
herp
bovin
type
sont
trt
frtquent
mai
le
form
de
la
maladi
sont
trt
varit
le
atteint
de
organ
gtnitaux
sont
le
plu
frtquent
cell
de
organ
respiratoir
varient
en
et
frtquenc
en
gtntral
de
indigest
sont
seulement
observt
chez
le
veaux
et
le
plu
souvent
en
belgiqu
le
avort
et
le
enctphalit
sont
observt
dart
quelqu
pay
de
mme
que
le
mammit
le
dermatit
et
le
de
espac
interdigitt
semblent
trt
rare
le
infect
par
bhvi
sont
souvent
compliqut
par
de
infect
bacttrienn
secondair
mai
il
est
aussi
bien
connu
que
linfect
avec
le
viru
de
la
diarrht
bovin
bvd
etou
le
parainfluenzaviru
pi
sont
concommittent
le
probltm
le
plu
import
cest
la
par
le
viru
de
devenir
latent
aprd
la
premitr
infect
le
gtnome
du
viru
rest
raisemblabl
pendant
la
vie
de
lanim
dan
le
ganglion
de
la
rtgion
de
la
primo
infect
la
vaccin
ne
peut
venir
fi
bout
de
cett
situat
la
vaccin
peut
emptcher
lapparit
de
sign
cliniqu
de
la
maladi
mai
il
est
imposs
dempcher
linfect
suivi
dun
dtvelopp
de
la
latenc
le
programm
dtradic
en
autrich
danemark
et
suiss
ont
rtduit
le
hombr
de
animaux
stropositif
de
la
popul
bovin
un
programm
sanitair
est
aussi
mi
en
place
en
allemagn
motsclef
maladi
latenc
vaccin
vaccin
attenut
et
inactivt
programm
sanitair
et
diseas
caus
bovin
herpesviru
type
bhvi
member
herpesvirida
famili
subfamili
alphaherpesvirina
caus
great
concern
mani
countri
becam
known
viru
origin
believ
caus
infect
genit
tract
increas
capac
caus
diseas
almost
organ
system
viru
spread
worldwid
diseas
pattern
vari
contin
contin
countri
countri
assum
troubl
aris
border
ec
countri
remov
individu
diseas
diseas
origin
call
coital
exanthema
known
europ
year
affect
cattl
age
origin
name
suggest
gener
transmit
infect
bull
serv
femal
could
shown
horizont
spread
also
possibl
characterist
diseas
high
bodi
temperatur
lesion
vulvar
vagin
mucosa
resembl
plaqu
ie
area
epitheli
cell
destroy
replic
viru
vagin
discharg
day
humor
cellmedi
local
immun
follow
diseas
genit
tract
bull
occur
gener
bull
serv
infect
femal
also
shown
viru
spread
within
insemin
centr
variou
rout
infect
gener
limit
preputi
mucosa
distal
portion
urethra
semen
therefor
consid
free
viru
becom
contamin
ejacul
two
fact
render
bull
especi
danger
bull
continu
serv
follow
infect
lesion
becom
pain
day
pi
semen
contamin
high
amount
infecti
viru
cours
diseas
gener
somewhat
longer
femal
week
bull
mucosa
suffici
heal
resum
servic
unless
vaccin
programm
start
immun
femal
attent
drawn
diseas
origin
case
diagnos
western
usa
feedlot
condit
enabl
viru
increas
virul
respiratori
tract
numer
rapid
passag
diseas
character
sudden
onset
high
fever
loss
appetit
milk
product
follow
rapid
loss
weight
especi
fatten
cattl
nasal
discharg
first
serou
becom
mucoid
later
mucopurul
saliva
frothi
anim
treat
prevent
secondari
infect
high
percentag
succumb
pneumonia
die
proper
treatment
recoveri
fast
humor
cellmedi
local
immun
induc
conjunct
usual
associ
ibr
report
occur
separ
even
combin
genit
tract
infect
morexella
bovi
infect
occur
simultan
sever
keratoconjunct
result
enceph
relat
enceph
interest
mainli
oversea
countri
also
isol
case
enceph
germani
hungari
onset
also
rapid
affect
cattl
gener
calv
die
within
day
first
case
abort
occur
usa
follow
use
vaccin
properli
attenu
sinc
case
also
occur
european
countri
tabl
like
import
viru
interest
note
necessari
adult
pregnant
cattl
demonstr
distinct
clinic
symptom
prior
abort
usual
occur
last
trimest
pregnanc
remark
digest
tract
diseas
caus
concern
belgium
european
countri
earli
caus
frequent
fatal
diarrhoea
calv
wherea
shown
induc
mild
diarrhoea
case
adult
cattl
viru
replic
caudal
portion
colon
rectum
ph
gut
content
close
shown
franc
oversea
caus
catarrh
type
mastiti
viru
reach
mammari
gland
may
howev
frequent
overlook
incid
mastiti
decreas
exampl
herd
vaccin
report
describ
isol
case
assum
manifest
connect
disord
recent
attent
drawn
question
frequent
shown
associ
viru
infect
first
report
isol
togeth
bvdv
two
fatal
case
calv
anoth
two
case
bovin
coronaviru
involv
one
one
case
resp
bvd
viru
found
second
report
associ
bvd
viru
infect
case
numer
report
avail
africa
america
europ
sporad
report
norway
finland
scotland
tabl
data
concern
europ
summar
confirm
viru
andor
antigen
possibl
convent
method
cell
cultur
immunofluoresc
immunoperoxidas
assay
elisa
proof
presenc
viral
genom
situ
hybrid
pcr
techniqu
suitabl
antibodi
detect
numer
serolog
method
serum
neutral
plaqu
reduct
immunodiffus
passiv
haemagglutin
test
elisa
counterimmunolectrophoresi
micro
complement
fixat
also
use
late
intraderm
test
introduc
wherebi
exampl
possibl
differenti
passiv
activ
acquir
immun
follow
infect
local
humor
cellmedi
immun
induc
method
avail
measur
actual
content
variou
immunoglobulin
milk
blood
serum
practic
valu
control
proper
administr
colostrum
shown
titer
humor
antibodi
newborn
may
exceed
dam
suffici
quantiti
colostrum
minimum
ml
first
h
given
mix
infect
viru
antibodi
respons
delay
significantli
lower
singl
infect
follow
infect
latenc
establish
ganglia
respect
organ
system
primari
infect
occur
stress
situat
transport
dystocia
heifer
case
mucos
diseas
immunosuppress
corticosteroid
applic
viru
shed
respect
tract
trial
infect
produc
intraven
inocul
result
differ
infect
occur
via
natur
entranc
recrudesc
may
influenc
composit
immunosuppress
corticosteroid
recent
experi
could
clearli
demonstr
heifer
inocul
intranas
shed
viru
respiratori
tract
immunosuppress
earli
public
frequent
result
wrong
conclus
shown
fig
follow
local
infect
period
viru
excret
shorten
anim
reinfect
certain
correl
exist
humor
antibodi
titer
day
viru
excret
wrong
interpret
claim
correl
exist
humor
antibodi
matter
obtain
abil
shed
viru
therefor
number
experi
conduct
prove
correl
humor
antibodi
titer
readi
shed
viru
also
durat
viru
shed
follow
immunosuppress
group
consist
anim
latent
infect
follow
intranas
inocul
field
vaccin
strain
immunosuppress
result
demonstr
fig
anim
shed
viru
longest
day
fairli
high
titer
humor
antibodi
true
cattl
first
infect
field
viru
intranas
rout
twice
vaccin
week
interv
inactiv
vaccin
licens
germani
immunosuppress
viru
could
recov
period
day
presenc
high
humor
antibodi
titer
fig
third
group
anim
twice
vaccin
inactiv
vaccin
week
interv
challeng
field
viru
three
month
later
immunosuppress
carri
result
present
fig
remark
anim
excret
viru
short
period
time
major
longer
period
time
anim
group
fourth
group
anim
vaccin
intranas
experiment
inactiv
vaccin
earlier
experi
produc
encourag
result
fmd
vaccin
studi
anim
challeng
week
later
field
viru
month
later
immunosuppress
result
viru
recoveri
seen
howev
correl
amount
viru
excret
seroneg
seroposit
cattl
follow
challeng
numer
trial
shown
epizootiolog
point
view
less
import
sinc
infecti
dose
low
recent
experi
yet
complet
found
cattl
vaccin
intranas
three
time
reluct
shed
viru
applic
immunosuppress
corticosteroid
even
increas
dosag
numer
monoval
multival
vaccin
licens
throughout
world
summari
licens
ec
countri
given
tabl
vaccin
present
avail
group
follow
live
attenu
vaccin
b
live
tsmutant
c
inactiv
vaccin
subunit
vaccin
live
attenu
vaccin
first
licens
usa
deriv
ibr
viru
strain
wherea
one
licens
germani
elsewher
ipv
strain
obviou
must
differ
one
deriv
ibr
strain
harbour
danger
caus
abort
least
number
administ
pregnant
cattl
wherea
one
deriv
ipv
strain
obvious
consid
safe
advantag
attenu
strain
base
possibl
use
emerg
ie
first
anim
herd
stricken
viru
possibl
prevent
spread
anim
yet
infect
anoth
advantag
especi
use
fatten
unit
feedlot
effect
caus
product
high
level
interferon
upper
respiratori
tract
protect
consid
superior
induc
vaccin
furthermor
base
induct
immunoglobulin
class
lga
protect
achiev
day
post
vaccin
disadvantag
possibl
spread
nonvaccin
possibl
recombin
field
viru
howev
occur
year
sinc
introduct
vaccin
germani
also
postul
mutat
wild
viru
may
occur
also
evid
phenomenon
occur
live
tsmutant
vaccin
market
ec
countri
especi
construct
protect
ibr
replic
cooler
portion
respiratori
tract
appear
therefor
less
apt
use
prophylact
measur
genit
diseas
also
shown
prevent
establish
latenc
field
viru
strain
whether
also
true
live
attenu
strain
proven
satisfactorili
wherea
live
attenu
vaccin
administ
local
parenter
possibl
adminst
licens
inactiv
vaccin
local
shown
inactiv
vaccin
induc
fairli
high
level
humor
antibodi
disadvantag
fact
use
emerg
tool
otherwis
consid
safe
true
subunit
vaccin
advantag
consid
base
lessen
chanc
induc
allerg
type
reaction
anim
time
offer
advantag
inactiv
vaccin
base
inactiv
whole
virion
manufactur
recommend
use
vaccin
whether
live
inactiv
seroneg
cattl
twice
week
interv
follow
half
year
yearli
repeat
vaccin
also
demonstr
useless
repeat
vaccin
interv
week
site
applic
parenter
vaccin
subcutan
rout
wherea
live
attenu
vaccin
administ
local
ie
respiratori
genit
tract
also
advis
spray
small
amount
eye
give
protect
natur
entranc
must
point
vaccin
abl
prevent
diseas
infect
follow
establish
latenc
field
pseudorabi
shown
viru
vaccin
delet
one
glycoprotein
still
produc
good
protect
vaccin
anim
furthermor
allow
veterinari
profess
differenti
well
anim
vaccin
anim
infect
field
viru
possibl
true
vaccin
present
develop
number
compani
howev
alreadi
known
possibl
simpli
copi
pseudorabi
vaccin
develop
major
glycoprotein
respons
induct
immun
consid
gi
glv
whether
possibl
develop
efficaci
antiidiotyp
vaccin
remain
determin
true
recombin
vaccin
far
experi
conduct
use
vaccinia
viru
carrier
question
viru
use
experiment
studi
unsuit
use
cattl
vaccin
commerci
basi
popul
free
orthopoxvirus
vaccinia
belong
unlicens
vaccin
trial
use
vacciniaviru
carrier
rabiesviru
compon
prove
disastr
vector
may
suitabl
consid
investig
certainli
also
unsuit
immun
respons
field
viru
strain
extrem
weak
question
whether
final
possibl
develop
peptid
vaccin
answer
present
vaccin
would
certainli
best
would
free
nucleic
acid
could
probabl
store
almost
indefinit
would
like
requir
refriger
import
field
far
neglect
late
discuss
detail
describ
exampl
variou
strain
group
togeth
composit
like
relat
practic
aspect
seem
differ
two
titl
inde
one
erad
mean
freedom
whole
cattl
popul
countri
state
sanit
mean
elimin
herd
group
organis
breeder
erad
programm
vaccin
prohibit
sanit
programm
may
use
europ
three
countri
conduct
erad
programm
austria
denmark
switzerland
prerequisit
programm
low
preval
rate
switzerland
start
exampl
rate
seroposit
cattl
total
popul
preval
rate
begin
similar
countri
gener
idea
method
procedur
countri
outlin
fig
test
slaughter
polici
cours
depend
financi
situat
countri
compens
paid
breed
anim
question
circumst
programm
conduct
whether
one
start
live
inactiv
resp
subunit
vaccin
depend
percentag
seroposit
cattl
herd
also
size
scheme
recommend
fig
base
knowledg
obtain
survey
experi
field
trial
therebi
risk
accept
seroposit
anim
alway
shed
infecti
viru
mention
earlier
higher
number
riskier
procedur
start
inactiv
vaccin
rightaway
